Shares of Docusign DOCU have gained 6.1% over the past month, outperforming the Zacks S&P 500 Composite’s 1.5% growth. DOCU has a Growth Score of A, which condenses key financial metrics to reflect a ...

Salesforce CRM stock: Shares dropped 7% Tuesday as Adobe downgrade triggered software sector sell-off. Feb 25 earnings in ...

Software development isn't what it used to be. Thanks to the rapid emergence of what's known as "vibe coding", a new approach ...

Automating manual processes improves efficiency and eliminates human error. Learn about workflow automation and how to create ...

Earlier this month, DocuSign marked ten years in Ireland by committing EUR4.5 million to expand its Dublin AI Centre of Excellence and grow its engineering team by 20%, underscoring the city’s role as ...

On December 17, BTIG analyst Allan Verkhovski initiated coverage of DocuSign, Inc. (NASDAQ:DOCU) with a Buy rating and an $88 price target. Shares are down 34% from their multi-year high of $107 last ...

A new report out today from cybersecurity company Forcepoint LLC’s X-Labs research team has uncovered a spike in holiday-themed phishing activity that blends impostor Docusign credential harvesting ...

DocuSign Inc. (NASDAQ:DOCU) ranks among the best high growth stocks to buy now. Citing DocuSign Inc. (NASDAQ:DOCU)’s leading position in the e-signature sector, Citizens reaffirmed its Market ...

KJ Muldoon received a groundbreaking new treatment earlier this year. The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead ...

PHILADELPHIA (WPVI) -- A miracle baby who was treated with a pioneering gene-therapy at Children's Hospital of Philadelphia has reached a major milestone as he took his first steps. KJ Muldoon was the ...

During infection, the human immunodeficiency virus (HIV) inserts itself into the host genome as a chromosomally-integrated provirus that persists in infected cells. Although antiretroviral therapies ...